MedPath

Prevention of Migraine in Adolescents.

Completed
Registration Number
NL-OMON21202
Lead Sponsor
uts/Ohra
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Candidates are migraine patients, aged 13 to 18 years, living in Rotterdam.

Exclusion Criteria

Patients suffering from asthma, allergies and diabetes are excluded as well as patients who’ve been using propanolol and/or relaxation therapy as a treatment less then 6 months before the start of the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Perceived effect and change of intensity, frequence and duration of migraine attacks.
Secondary Outcome Measures
NameTimeMethod
Change in 'quality of life'- experience, number of schooldays missed and medical consumption.
© Copyright 2025. All Rights Reserved by MedPath